Novo Nordisk (NVO) asked the Food and Drug Administration to approve a pill version of its popular weight loss drug in obesity earlier this year, a spokesperson confirmed to BioPharma Dive ...

Novo Nordisk (NYSE:NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...

RedHill Biopharma (RDHL) announced that the Company received a written notification from the Listing Qualifications Department of the Nasdaq Stock Market dated April 15, notifying the Company that ...

Novo Nordisk (NYSE:NVO) has filed for U.S. approval of an oral version of its blockbuster weight loss drug Wegovy, the company confirmed to BioPharma Dive. The Danish drugmaker disclosed the ...

A group of UnitedHealth shareholders have pulled a plan to require the massive insurance company to analyze the impact of healthcare delays and denials after UnitedHealth challenged the proposal ...

After Trump moved to cut indirect funding for medical research and began to halt funding for National Institutes for Health grants, a spokesperson for UNC Health told Healthcare Dive the health ...

Ulysse Nardin has debuted the world’s lightest mechanical dive watch at Watches and Wonders. The Ulysse Nardin Diver [Air] has a skeletonised dial and has had its weight cut in half by removing ...

The median funding round involving one of the roughly two dozen venture firms tracked by BioPharma Dive was worth $93 million during the first three months of 2025, according to BioPharma Dive data.

Are the top two rookie tight end prospects in the 2025 draft fighting some rare history to be a great Fantasy Football asset, or are they next in a brand-spankin-new trend? Last year, Brock Bowers ...

Open now and remaining in situ until June, Anya's Dive Shop kicks off the spring/summer season with a celebration of underwater escapism. From the brightly painted exterior and XL shark sculpture ...

NEW YORK (AP) — U.S. stocks dove Tuesday following another stunning reversal, with Wall Street veering from a huge gain at the opening of trading to more losses at the close, because investors ...

Merck KGaA’s proposed acquisition of SpringWorks Therapeutics is the first biotech buyout tracked by BioPharma Dive to eclipse the billion-dollar mark since mid-January.